key: cord-1002606-ks4dc0z3
authors: Mortimer, Philip
title: A comparison with historical influenza prompts better planning for Covid‐19 and future pandemics, and gives grounds for optimism
date: 2021-10-29
journal: Rev Med Virol
DOI: 10.1002/rmv.2307
sha: c010f06df3c1d182c083d34c970325c234db555f
doc_id: 1002606
cord_uid: ks4dc0z3

nan

The emergence of SARS-CoV-2 'variants of concern/interest' reflects genomic drifting, and may soon necessitate vaccine modification. While the interval between the appearance of SARS and SARS-2 is comparable with that between influenza pandemics, a third The stark fact is that vaccine hesitancy and refusal have to be overcome. Until there is very substantial global vaccine coverage Covid-19 is likely to remain endemic, and so its associated mortality will have to be accepted and its collateral effects accommodated.

Culturally appropriate means therefore need to be devised to persuade people to accept vaccination even while individuals' autonomy, including that of the parents of children, is respected. A particular issue, the safety of vaccines and antiviral drugs in pregnancy, previously discussed in relation to influenza, 7 has yet to be addressed. with a specific antiviral drug has been equally disappointing, probably because it is not being given at the first opportunity. Expensive antiviral treatment is typically being reserved for severe cases 10 or more days after onset, long after the peak of virus replication.

There is as yet no published series of Covid-19 cases promptly treated with remdesivir, the antiviral drug most active against SARS-2 virus in the laboratory and in experimental animals; but it is on record that it was given to US President Trump the day after he was diagnosed with Covid-19. He rapidly recovered. In the future those who seem to be developing a pandemic virus infection and are recognisably susceptible through advanced age and/or clinical vulnerability might receive an early home/care-home assessment with a view to immediate even if brief antiviral treatment especially if this can be given orally.

The striking development of mRNA Covid-19 vaccines implies that vaccines will be the best defence against future pandemics, whether coronavirus, influenza, or another virus. The Western democracies have experienced prolonged social disruption and economic damage due to their chosen defence against Covid-19. They must now plan to meet future pandemics with a timely vaccine Whether SARS-2 evolved naturally or is perhaps a laboratory escapee from a biosafe and biosecure 1 laboratory, testing needs to be made available to allow investigation of what are often remote outbreaks. Pandemics also require laboratory assay standardisation. The critical measurements of Covid-19 infectiousness and immunity have lacked this, and reporting of quantifying PCR signal thresholds is still not routine.

The spread of the first SARS virus was suppressed by the isolation of patients and the tracing of their contacts, but these measures never had a significant role in the containment of human influenza and they have proved difficult to apply to Covid-19. It has a short incubation period in which it quickly becomes infectious to contacts, and it remains so for several days. There is not, as there was for smallpox, a post-exposure interval of several days during which vaccine could be given, and even with the advantage of smartphones, contact tracing is often not effective. Though phoneenabled contact tracing is the mainstay of pandemic control, 8 it has encountered opposition from those who seek to guard their privacy.

In conclusion: a comparison with past influenza pandemics is instructive: analogy suggests that the world is actually much better placed to deal with threatened viral pandemics than before. Covid-19 will probably persist until vaccination can become near universal, but recent progress in vaccinology and antiviral drug discovery has made prophylaxis and hopefully early treatment possible. With more persuasive incentives to accept immunisation, sufficient scientific and 

Consensus is needed at a global level concerning dual-use research

Encephalitis lethargica: 100 years after the epidemic

Royal Free Disease after 65 years: what was it and what has become of it

Confronting our next National Health Disaster -long-haul Covid

Pandemics throughout history

SARS-CoV-2 human challenge studies -establishing the model during an evolving pandemic

Pandemic influenza A(H1N1) 2009 virus in pregnancy

Contact tracing for Covid-19 -a digital inoculation against future pandemics